iiinova — where your digital self keeps evolving

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 29/09/2026

The Psychedelic Lived Experiences Summit returns Nov 20–22. Beyond the Protocol: safety, real-world outcomes & support gaps after psychedelic treatment. 3 days 12 live roundtables & panels 50+ contributors Standard $79 · Student $29 · Scholarships available psychedeliclivedexperiences.com/summit

Event flyer for the Psychedelic Lived Experiences Summit 2026, “Beyond the Protocol,” taking place online November 20–22. Features 20 contributor headshots and highlights 50+ contributors, 3 days, 9 working roundtables, and 3 synthesis panels.

020

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 25/09/2026

Decisions that affect us should be made with us. This isn’t about placing one form of expertise above another. It means giving lived experience the same seat at the table as clinical, scientific, and policy expertise. And real agency in decisions that affect patients.

000

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 30/06/2026

On paper, a trial can look robust. But participants do not live through protocols on paper. They live through the real experience, and that does not always fit neatly into the design. Methodological rigor matters. It just does not automatically mean lived safety. #Psychedelics #CllinicalTrials

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 24/06/2026

Grateful for the impact of this podcast. We’re also inspired by Australia’s leadership in meaningfully centering lived experience in psychedelic care and policy. Thank you Dr Esme Dark. www.youtube.com/watch?v=fnuy... #psychedelic #livedexperience #PatientCare

youtube.com

Pedram Dara Centering Lived Experience in Psychedelic Care

YouTube video by Beyond the Trip: A Psychedelic Therapy Podcast

020

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 23/06/2026

In clinical trials and practice, safety is often understood through what gets formally documented as an adverse event. That matters. But it does not always capture the full reality of what participants may be living through. #PsychedelicResearch #PsychedelicTherapy #ClinicalTrials #ClinicalResearch

330

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 09/06/2026

Some people go through clinical trials and move on. Others stay with what they saw, what they lived, and what they believe needs to change. Two years into Psychedelic Lived Experiences, this clip reflects the heart of why this work exists. #psychedelics #clinicaltrials #livedexperienceexpertise

120

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 20/05/2026

Today is International Clinical Trials Day. Clinical research depends on participants, not just protocols. Beyond data, they contribute time, trust, vulnerability and lived insight. To all clinical trial participants and those working to improve them: thank you. #ClinicalTrialsDay

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 30/04/2026

What Participant Screening Really Felt Like in an MDMA Therapy for PTSD Trial Ron reflects on the emotional and physical toll of screening and clinical questionnaires, even when the goal is to understand and validate what someone has been through. #MDMATherapy #PTSD #Psychedelics #MDMA

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 29/04/2026

What participants live through is often treated as anecdotal, when in reality it can reveal exactly what formal systems fail to capture. That is not noise. That is part of the signal. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials

240

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 21/04/2026

The Philosophical Foundations of Lived and Living Experience in Psychedelic Therapy Meet @tehseennoorani.bsky.social, PhD, social scientist and facilitator of the Reimagining Psychedelic Trials working group. #PsychedelicTherapy #PsychedelicResearch #Psychedelics #LivedExperience

230

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 17/04/2026

The ride is never what the outside world sees. A nod to Dr. Albert Hofmann and his famous bicycle ride on April 19, 1943. History can tell us what happened. Lived experience tells us what it was like. #BicycleDay #AlbertHofmann #Psychedelics #LivedExperience

262

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 14/04/2026

What Mattered More Than Getting the Medicine or Placebo Meet Elizabeth Lamphere, a clinical trial participant who received placebo in an MDMA-assisted therapy study for PTSD. #MDMATherapy #PsychedelicResearch #ClinicalTrials #Placebo #PTSD

240

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 13/04/2026

A 2017 qualitative psilocybin study by Dr Rosalind Watts found participants describing changes not only in symptoms, but in connectedness and acceptance. A useful reminder that lived experience can reveal forms of change standard outcome measures may miss. #Psilocybin #Depression #LivedExperience

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 09/04/2026

Why Lived Experience Matters in Psychedelic Professional Training Meet Monnica Williams, PhD, @drmonnica.bsky.social clinical psychologist, researcher, and professor in the School of Psychology at the University of Ottawa. #PsychedelicTherapy #PsychedelicResearch #TherapistTraining #Psychedelics

231

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 08/04/2026

Informed consent matters. But it is not the same as safety. A person can be fully informed on paper and still be unprepared for what participation or treatment actually feels like. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 07/04/2026

How a Dedicated Care Team Can Make Participants Feel Safer Meet Becca Kacanda, @beccakacanda.bsky.social a trial participant in MDMA-assisted therapy for PTSD. She shares how the care she received felt different from standard therapy. #PsychedelicResearch #PatientSafety #ClinicalTrials

240

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 06/04/2026

Are you a clinician, therapist, researcher, QA, program lead, or study staff? Discover how to leverage lived experience as quality and safety infrastructure in psychedelic care. 🗓 Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC (19:00 Central Europe) #psychedelics #PatientSafety #LivedExperience

321

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 02/04/2026

What Makes a Competent Psychedelic Therapist Beyond Degrees Meet Matthew Johnson, PhD, psychedelic researcher, experimental psychologist, senior investigator, and professor at Johns Hopkins University. #Psychedelics #PsychedelicResearch #PatientCenteredCare

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 01/04/2026

Lived experience is not only about sharing stories. It can reveal blind spots, improve quality and safety, and lead to better decisions in research and care. The question is whether the field is willing to treat it as expertise, not just perspective. #Psychedelics #LivedExperience #ClinicalTrials

230

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 31/03/2026

What Placebo Can Cost Participants in Prolonged Crossover Trials Meet Kathy Neustadt, a clinical trial participant who received placebo in an MDMA-assisted therapy research for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #ClinicalTrials #placeboeffect

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 30/03/2026

Lived experience may be welcomed into the conversation, but rarely trusted with real authority. That gap matters. Because inclusion is not the same as influence, and consultation is not the same as shared decision-making. #Psychedelics #LivedExperienceExpertise #ClinicalTrials

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 29/03/2026

Upcoming workshop: Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC (19:00 Central Europe) Discover how to leverage lived experience as quality and safety infrastructure in psychedelic care. #PsychedelicTherapy #PsychedelicResearch #PatientSafety #LivedExperience #ClinicalTrials

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 27/03/2026

In 2023, the FDA issued draft guidance on clinical investigations for psychedelic drugs. The document says it is meant to give sponsors general considerations for developing psychedelic drugs for medical conditions, including trial conduct, data collection, and subject safety. #Psychedelics #FDA

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 26/03/2026

When Lived Experience Is Shared on Stage, Safety Matters Meet Joost Breeksema, PhD, a qualitative researcher in psychedelic trials and Executive Director of the OPEN Foundation in the Netherlands, which organizes the ICPR conference (June 4-6, 2026). #Psychedelics #PsychedelicResearch

231

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 25/03/2026

In psychedelic care, safety is often about the dosing day. If we want a more honest standard, safety cannot mean only “nothing visibly went wrong during treatment.” It has to include what happens after, when real life resumes. #PsychedelicResearch #PatientSafety #ClinicalTrials #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 24/03/2026

Psilocybin Therapy for Anxiety: Building Safety and Trust Before Dosing Leonie reflects on what helped her feel safe entering the trial and what built trust before dosing. She shares how preparation played an important role in creating a greater sense of safety. #Psychedelics #Psilocybin

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 23/03/2026

In psychedelic care, safety is often framed around screening, dosing, supervision, and acute adverse events. Those matter. But they are not the whole picture. If safety only means “nothing visibly went wrong in the room,” the standard is too low. #Psychedelics #PatientSafety

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 22/03/2026

Joining this workshop? Lived Experience as Quality and Safety Infrastructure in Psychedelic Care 🗓 Apr 11, 2026 • 10 AM PT / 1 PM ET / 17:00 UTC If you’re a clinician/therapist, researcher, QA, program lead, or study staff, this is for you. #PsychedelicTherapy #PsychedelicResearch #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 20/03/2026

Eligibility criteria are necessary. They help ensure safety, consistency, and rigor in research. But they also simplify. People don’t arrive as clean variables. They arrive with overlapping histories, contexts, and contradictions. #PsychedelicResearch #PatientCenteredCare #Psychedelics

230

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 19/03/2026

Why Individual Treatment May Not Be Enough in Psychedelic Care Meet Chris Stauffer, MD, psychiatrist, addiction medicine specialist, and investigator of group MDMA therapy for veterans with PTSD. #PsychedelicTherapy #PsychedelicResearch #PeerSupport #LivedExperience #MDMAtherapy

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 18/03/2026

Live workshop — Apr 11, 2026. Lived Experience as Quality and Safety Infrastructure in Psychedelic Care Frameworks + checklist to integrate lived experience into research and care (without tokenism). No Professional Pass yet? Get one to join. Link in bio. #psychedelics #PatientSafety

320

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 17/03/2026

What Being Taken Off the Clinical Trial Really Felt Like Meet Kerrilee Barrett, a mental health practitioner who participated in a clinical trial involving a psychoactive substance for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #Psychedelics

221

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 13/03/2026

For decades, mental health innovation has claimed to include the voices of people with lived experience. But how much influence do those voices actually have? Paper: mental.jmir.org/2023/1/e46590 #MentalHealthResearch #PatientCenteredCare #LivedExperience #MentalHealthInnovation

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 12/03/2026

Ibogaine Care and Why Lived Experience Matters Meet Jonathan Dickinson, a psychologist, renowned Ibogaine expert, published researcher, and CEO & co-founder at Ambio Life Sciences. #PsychedelicTherapy #PsychedelicResearch #LivedExperience #Ibogaine #Iboga #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 11/03/2026

Psychedelic clinical trials often focus on symptom reduction. That matters, but it is not the full story. A participant can look improved on a clinical scale while still struggling with stability, relationships, meaning-making, or life after the protocol ends. #PsychedelicResearch #ClinicalTrials

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 10/03/2026

How Psilocybin Therapy Changed the Way I Process Emotions Meet Daryna Skybina, MPS who participated in a clinical trial studying psilocybin-assisted therapy for people with advanced cancer. #PsychedelicTherapy #PsychedelicResearch #LivedExperience #CancerResearch #PatientVoices #Psychedelics

240

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 09/03/2026

Safety in psychedelic care cannot rely only on protocols, clinical training, or symptom scores. The people who go through these treatments often see risks, challenges, and gaps that formal systems miss. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 06/03/2026

Are Psychedelic Experiences Just Brain Activity? Bill reflects on a debate between Guy Goodwin and Max Wolff @trpwolff.bsky.social where it was suggested what people say about their experiences may be a kind of smokescreen and that the real explanation lies only in what is happening in the brain.

231

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 05/03/2026

Psychedelic clinical trials measure important outcomes. But the people who go through these experiences often see dimensions of healing and challenge that standard frameworks miss. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 04/03/2026

Psilocybin Therapy for Depression Can Be Both Healing and Destabilizing Meet Heather Joy, a clinical trial participant in an open-label psilocybin-assisted therapy study for treatment-resistant depression. #PsychedelicTherapy #PsychedelicResearch #Psilocybin #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 03/03/2026

In psychedelic research, improvement is often measured through symptom scales. MADRS scores drop. CAPS scores decrease. PHQ-9 improves. GAD-7 declines. That matters. But participants often struggle with: Identity. Relationships. Career. Spiritual. Stability. #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 02/03/2026

Destigmatization, Legalization, and Why Clear Rules Protect Patients Meet Janina Kowalski, MD, a psychiatrist who underwent ketamine, MDMA, LSD, and psilocybin in experiential therapist training. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #PsychedelicScience

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 27/02/2026

A psychedelic integration therapy session might last 60 minutes. Integration itself can last months, maybe years. Clinical care is essential. But transformation doesn’t confine to calendar blocks. This is why lived experience matters in how we design care. #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 26/02/2026

Beyond Lip Service: Meaningful Inclusion of Lived Experience Meet Simon Amar, MD, a psychiatrist and investigator for MDMA for PTSD and psilocybin for anxiety clinical trials #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 25/02/2026

Psychedelic clinical trial participants contribute more than data. They contribute time. Vulnerability. Personal history. Emotional labor. In most cases, they are not systematically informed when results are published, or engaged in how findings are interpreted. #Psychedelics

240

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 24/02/2026

MDMA-Assisted Therapy Trial: Safety, Trust, and Returning to Work Meet Sehrish Sayani, who participated in a Phase 3 MDMA-assisted therapy clinical trial for PTSD. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 23/02/2026

William James helped lay the foundations of modern psychology. And yet his insight still challenges us: What we choose to attend to shapes what we call knowledge. #PsychedelicTherapy #PsychedelicResearch #PatientCenteredCare #LivedExperience #PsychedelicScience #Psychedelics

220

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 20/02/2026

The Importance of Sharing Nuanced and Difficult Psychedelic Experiences Meet Will Barone, Psy.D, a clinical psychologist and qualitative researcher in studies with MDMA, psilocybin, & ketamine #PsychedelicTherapy #PsychedelicResearch #LivedExperience #PsychedelicScience

120

Psychedelic Lived Experiences @psych-lived-exp.bsky.social · 19/02/2026

Psychedelic clinical research is advancing rapidly. While it’s optimizing for measurable outcomes, many participants describe changes that don’t fit neatly into a scale. If we want safer and more durable models of care, lived experience must become structural. #Psychedelics

220